Indaptus Therapeutics Inc [NASDAQ: INDP] traded at a low on Tuesday, posting a -0.28 loss after which it closed the day’ session at $0.81.
The results of the trading session contributed to over 17948062 shares changing hands. Over the past one week, the price volatility of Indaptus Therapeutics Inc stands at 34.60% while the volatility over the past one month is 14.57%.
The market cap for INDP stock reached $11.69 million, with 14.43 million shares outstanding and 11.61 million shares in the current float. Compared to the average trading volume of 24.16K shares, INDP reached a trading volume of 17948062 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Indaptus Therapeutics Inc [INDP]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for INDP shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on INDP stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Indaptus Therapeutics Inc is set at 0.13 The Price to Book ratio for the last quarter was 1.38, with the Price to Cash per share for the same quarter was set at 0.51.
How has INDP stock performed recently?
Indaptus Therapeutics Inc [INDP] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.57. With this latest performance, INDP shares gained by 1.38% in over the last four-week period, additionally sinking by -46.36% over the last 6 months – not to mention a drop of -57.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for INDP stock in for the last two-week period is set at 47.91, with the RSI for the last a single of trading hit 48.50, and the three-weeks RSI is set at 46.88 for Indaptus Therapeutics Inc [INDP]. The present Moving Average for the last 50 days of trading for this stock 0.8503, while it was recorded at 0.8148 for the last single week of trading, and 1.3975 for the last 200 days.
Indaptus Therapeutics Inc [INDP]: Deeper insight into the fundamentals
Indaptus Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.42 and a Current Ratio set at 3.42.
Earnings analysis for Indaptus Therapeutics Inc [INDP]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for INDP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Indaptus Therapeutics Inc go to 26.86%.
Insider trade positions for Indaptus Therapeutics Inc [INDP]
There are presently around $14.20%, or 24.49%% of INDP stock, in the hands of institutional investors. The top three institutional holders of INDP stocks are: VANGUARD GROUP INC with ownership of 0.26 million shares, which is approximately 3.0355%. INVESTMENT HOUSE LLC, holding 0.1 million shares of the stock with an approximate value of $$0.22 million in INDP stocks shares; and INVESTMENT HOUSE LLC, currently with $$0.13 million in INDP stock with ownership which is approximately 0.7025%.
